Oxford University Hospitals NHS FT
1.6. Research also features prominently in OUH's NMAHPs strategy (2021-26) and in Our Clinical Strategy (2023-28).
TB2026.67
2. Structure and Organisation
2.1. An organogram summarising the structure and organisation of OUH Research and Development (R&D) is shown below (Figure 1).
Figure 1. OUH R&D Organogram
2.2. In addition to this annual report to the Trust Board, R&D provides reports quarterly to the Joint R&D Committee (JRDC) and the Trust Management Executive (TME).
2.3. The JRDC was established in 2011 under the Joint Working Agreement between OUH and the University of Oxford (OU).
2.4. The OUH R&D teams are part of the Joint Research Office (JRO), a partnership with the University of Oxford, Oxford Health NHS Foundation Trust and Oxford Brookes University. The JRO is overseen by the JRDC.
2.5. The potential to further integrate and strengthen the JRO has been recognised by both OUH and the Oxford Academic Health Partners (OAHP), which has as one of its short-term goals to “create an integrated Oxford Joint Research Office across all OAHP partners to promote operational collaboration”. The necessity to improve study set-up speed at OUH has given this work added impetus and a